To be or not to be on: aspirin and coronary artery bypass graft surgery

To be or not to be on: aspirin and coronary artery bypass graft surgery

Aspirin's role in secondary prevention for patients with known coronary artery disease (CAD) is well established, validated by numerous landmark trials over the past several decades. However, its perioperative use in coronary artery bypass graft (CABG) surgery remains contentious due to the del...

ver descrição completa

Detalhes bibliográficos
Main Authors: Aashray K. Gupta, Joshua G. Kovoor, Alasdair Leslie, Peter Litwin, Brandon Stretton, Ammar Zaka, Pramesh Kovoor, Stephen Bacchi, Jayme S. Bennetts, Guy J. Maddern
Formato: Artigo
Idioma:English
Publicado em: Frontiers Media S.A. 2024-08-01
Colecção:Frontiers in Cardiovascular Medicine
Assuntos:
aspirin
coronary artery bypass graft (CABG) surgery
bleeding
perioperative care
outcomes
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1451337/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2024.1451337/full

Registos relacionados